Nuvectra Corporation (NASDAQ:NVTR) Files An 8-K Other Events
Item 8.01
|
Other Events. |
On November 16, 2016, the Company posted a presentation to its
internet website located at www.nuvectramed.com that it is
utilizing in connection with meetings with certain current and
prospective investors, suppliers and customers of the Company
(the Presentation). A copy of the Presentation is attached hereto
as Exhibit99.1 and is incorporated herein by reference. The
Presentation attached as Exhibit 99.1 discloses certain
information that is not presented in accordance with United
States generally accepted accounting principles (GAAP).
|
Item9.01 |
Financial Statements and Exhibits. |
(d)Exhibits.
|
99.1 |
Presentation posted to the Nuvectra website on November 16, |
About Nuvectra Corporation (NASDAQ:NVTR)
Nuvectra Corporation, formerly QIG Group, LLC, is a neurostimulation company. The Company is focused on the development and commercialization of a neurostimulation technology platform, which is used for the treatment of various disorders through stimulation of tissues associated with the nervous system. The Company’s Algovita spinal cord stimulation (SCS) system is an application of its neurostimulation technology platform, and is used for the treatment of chronic pain of the trunk and limbs. The Company’s technology platform supports other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, the Company, through its subsidiary, designs, manufactures and markets neural-interface technologies for the neuroscience pre-clinical research market. Nuvectra Corporation (NASDAQ:NVTR) Recent Trading Information
Nuvectra Corporation (NASDAQ:NVTR) closed its last trading session up +0.07 at 4.95 with 197,852 shares trading hands.
